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Abstract
The research was conducted to determine the effect of insulin-like growth factor-I
(IGF-I) derived from pregnant crossbred mare serum (PMS) on estrous cycle and litter
size in mice (Mus musculus). The research was arranged by Completely Randomized
Design (CRD) with seven treatments and five replications. The treatments were
control (CO)= physiological NaCl, treatment (T) 1 = 10 ng/ml of IGF-I pregnant mares
crossbred serum (PMS), T2 = 20 ng/ml of IGF-I PMS, T3 = 40 ng/ml of IGF-I PMS, T4 =
10 ng/ml of IGF-I recombinant mouse, T5 = 20 ng/ml of IGF-I recombinant mouse, and
T6 = 40 ng/ml of IGF-I recombinant mouse. Serie I the subject of this research were
35 female mice. Observed variables included estrous cycle phases that proestrus,
estrus, metestrus, and diestrus phase. Serie II for the objects of this research were
35 female mice and 21 male mice in the same treatment on litter size in mice. The
data were analyzed by Analysis of Variance (ANOVA), followed by HSD (Honestly
Significant Difference) test. The result showed that the addition of IGF-I PMS did not
significantly affect (p>0.05) on proestrus, metestrus, and diestrus phase. The addition
of IGF-I PMS 40 ng/ml was extended (p<0.05) the estrus phase. It showed that there
was not significantly difference (p>0.05) between the effect of IGF-I PMS and IGF-I
recombinant mouse with the mice estrous cycles. The result of IGF-I derived from
PMS and IGF-I recombinant mouse on litter size in mice did not significantly difference
(p>0.05). Test results shows significant differences between control and 40 ng/ml of
IGF-I PMS.
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Insulin-like growth factor-I (IGF-I) is one of bioactive material, a supplementation of
IGF-I in maturation and culture medium can stimulate and increase the number of
oocyte. Besides, it also can increase the result of in vitro fertilization (IVF) and the
amount of some livestock’s embryo, such as pigs [1], cows [2], and buffaloes [3], which
run into blastocyst. The addition of IGF-I during pig’s prenatal follicle culture can enlarge
the diameter of follicle. Meanwhile, mRNA insulin-like growth factor receptor-I (IGFR-I)
can be increased by adding FSH supplementation as far as the culture and oocyte are
able to do meiosis process after maturation [4]. One of the most important aspects in
animal reproduction is estrus cycle. Monitoring this cycle plays an important role for
fertilization and reproduction as it increases the number of animal population [5].
Nowadays, many researchers use bioactive to observe its effect toward estrous
cycle which purposes tomaintain the estrous cycle itself. One of bioactivematerial that
has important role in reproduction is insulin-like growth factor-I (IGF-I). IGF-I is involved
in increasing the proliferation of endometrium stromal cell of adult mice [6]. [7] who
quoted from many resources stated that IGF-I is a factor which control the follicle and
embryo growth. The quality of oocyte and embryo, result of superovulation, totally
depend on IGF-I concentration [8]. In vivo, IGF-I concentration in the follicle of cow’s
superovulation can increase the number of embryo [9]. [10] and [11] stated that the
addition of IGF-I into medium culture make the blastocyst percentage and embryo
resistance of heat stresses work up. Besides, IGF-I is able to increase the number of
lactating Cows pregnancy. Estrous cycle is one of important aspect in animal repro-
duction. Monitoring to this cycle will improve the success of animal fertilization and
reproduction in order to increase the number of animal population [5].
Adding the insulin-like growth factor-I and insulin-like growth factor binding protein-
3 can fasten the puberty of female mice and increase the number of offspring [12].
When the puberty is about to come, FSH in blood will increase and cause the pro-
cess of steroidogenesis and folliculogenesis. Steroidogenesis occurs in follicle cell; it
is influenced by LH and assisted by IGF-I and IGFBP. This process forms androstene-
dione and testosterone. They will get into granulose cells from follicle to be converted
into estradiol 17β through the process of aromatization which is influenced by FSH
and assisted by IGF-I and IGFBP. The increasing of estradiol 17β secretion by granulose
cells that is about to get ovulation causes the emergence of lust symptoms. Also, it
will stimulate the high rates of LH which cause the ovulation and the emergence of
ovum. The success of fertilization and embryo formation can be determined from the
number of ovulation; the escalation of the amount of ovulated egg cells and converge
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to spermatozoa which will produce more fetus [13]. [14] found that, for some species,
IGF-I escalates ovary activity by stimulating granulosa cells, theca cells, and mito-
genesis proliferation. IGF-I synergy with gonadotropin in stimulating steroidogenesis
[15]. stated that IGF-I concentration during the end of puberty (shortly before the first
proestrus) can advance the puberty onmice. Besides, IGF-I in pre-puberty can advance
puberty on primates as well.
According to the introduction above, this research is applied on mice by giving
insulin-like growth factor-I (IGF-I) pregnant crossbred mare serum (PMS) in which its
effect will be observed toward the estrous cycle and the amount of mice litter. This
biopotency test is also purposed to comparing the differences between the effect of
giving IGF-I PMS and the effect of giving IGF-I recombinant mouse.
2. Materials and methods
This research was conducted in Obstetric Veterinary Laboratory, Veterinary Reproduc-
tion Department, Faculty of Veterinary Medicine, Universitas Airlangga and Veterinary
Observation Laboratory during October 2015 until December 2015. The effect of insulin-
like growth factor-I (IGF-I) in lust cycle is mice strain Balb/C aged 35 days (under
puberty) and the weight are the same. The mice were obtained from Farm Veterinary
Center Surabaya. Meanwhile, the objects for the effect of IGF-I on the amount of
mice litter acquisition were 35 female mice aged 30-35 days and 21 male mice aged 2
months, and they were adapted for seven days.
Female mice were injected subcutaneously by IGF-I pregnant crossbreed mare
serum (PMS). The result of separation method Sodium Duodecyl Sulphate-
Polyacrilamide Gel Electrophoresis (SDS-PAGE) and Western Blot examination. IGF-I
was separated from the result by using elution method. It could be obtained that
eluate IGF-I PMS and eluate IGF-I level are determined by sandwich ELISA [16], and
IGF-I recombinant mouse, Cat#591406, Biolegend, San Diego, USA).
2.1. Dose determination
IGF-I dose, based on [17] research, is 10ng/ml which subcutaneously give significant
result in enhancing bone resorption. It aims to maintain normal bone mass and to
stimulate osteoclastogenesis on mice. On the other hand [18], added IGF-I dose: 5
ng/ml, 10 ng/ml, and 20 ng/ml onmorula growth from oocyte culture of prenatal sheep
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follicle. This research is using IGF-I PMS and IGF-I recombinant mouse 10 ng/ml, 20
ng/ml, and 40 ng/ml doses for each.
2.2. Examined animal treatment
Micewere injected by single dose IGF-I in the first day after seven days adaptation. The
procedure for serie I was injecting per subcutaneousmice in control (C) 0: physiological
NaCl, treatment (T) 1: 10 ng/ml IGF-I PMS, T2: 20 ng/ml IGF-I PMS, T3: 40 ng/ml IGF-I
PMS, T4: 10 ng/ml IGF-I recombinant mouse, T5: 20 ng/ml IGF-I recombinant mouse,
and T6: 40 ng/ml IGF-I recombinant mouse. The observation of estrous cycle was
regularly done every six hours for 10 days (2 periods of mice lust cycle normally) in
which there were 4 times inspections at 04.00 AM, 10.00 AM, 16.00 PM, and 22.00
PM. This observation is using vaginal smear as the method. Prepare vaginalsmear with
Giemsa staining, then observed by using microscope with 100-400x magnification to
determine themice estrous cycle phases: proestrus, estrus, metestrus, or diestrus [19].
Serie II was treated, like seri I, by giving the dose as follows: C0: physiological NaCl,
T1: 10 ng/ml IGF-I PMS, T2: 20 ng/ml IGF-I PMS, T3: 40 ng/ml IGF-I PMS, T4: 10 ng/ml
IGF-I recombinantmouse, T5: 20 ng/ml IGF-I recombinantmouse, and T6: 40 ng/ml IGF-
I recombinant mouse per subcutaneous. The injected female mice were gathered with
male mice (ratio 5:3) during one lust cycle. The observation would be done until the
female mice bear the offsprings in one pregnancy period and they would be counted
(± 21 days).
2.3. The calculation of lust cycle phase period
The frequency of estrous phase will be converted as the period of estrous cycle [19].
The function as follows:
𝑋 = 𝐴 × 𝑌𝐵
Note: X: estrous phase period (hour),
Y: examination period (hour)
A: frequency of each phase in one sample
B: frequency total of all phases
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T 1: Data of vaginal smear results on mice estrous cycle after given IGF-I PMS (hour).
Treatment Estrous Cycle (x±SD)
Proestrus Estrus Metestrus Diestrus
C0 12.60𝑎 ±3.91 14.40𝑎𝑏 ±3.91 28.20𝑎±6.57 64.80𝑎 ±6.90
T1 5.40𝑎 ±4.44 3.00𝑎 ±4.24 24.60𝑎 ±21.88 87.00𝑎 ±27.90
T2 8.40𝑎 ±6.84 4.20𝑎 ±4.02 16.80𝑎 ±18.68 90.60𝑎 ±25.04
T3 10.20𝑎 ±6.90 24.00𝑏 ±14.07 28.20𝑎 ±20.30 58.20𝑎 ±32.62
Note: The different superscript in one column shows significant difference (p<0.05)
2.4. Design of the Study
This research uses Completely Randomized Design (CRD). The conducted data, after
given IGF-I PMS and IGF-I recombinant mouse, would be analyzed by using ANOVA
(Analysis of Variance) examination and statistical program by using software SPSS 21
(Statistical Product and Service Solution 21). If there is significant difference (p<0.05),
then continue it with Honestly Significant Different (HSD) examination [21]. The analy-
sis was used to compare two treatment factors: IGF-I PMS and IGF-I, by using General
Linear Model Univariate.
3. Results
3.1. The effect of IGF-I PMS and IGF-I recombinant mouse
on mice estrous cycle
The result of vaginal smear on mice estrous cycle after given IGF-I PMS will be pre-
sented in Table 1.
Based on the result of mice’s vaginal smear in estrous cycle after given IGF-I PMS,
it shows that there is difference in this phase. Yet, giving IGF-I PMS does not cause
significant difference (p>0.05) from the period of proestrus, metestrus, and diestrus
phase in the treatments of T1, T2, and T3IGF-I PMS in the doses of 40 ng/ml and T3
treatment leads estrous phase get longer significantly (p<0.05). The result of mice’s
vaginal smear in estrous cycle after given IGF-I recombinant mouse is presented in
Table 2.
Adding IGF-I recombinant mouse gives an effect on mice’s estrous cycle. Various
doses of IGF-I recombinant mouse does not show significant difference (p>0.05) from
the period of proestrus and estrous phase in the treatment of T4, T5, andT6. IGF-I
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T 2: Data of vaginal smear result on mice estrous cycle after given IGF-I recombinant mouse (hour).
Treatment Estrous Cycle (x±SD)
Proestrus Estrous Metestrus Diestrus
C0 12.60𝑎 ± 3.91 14.40𝑎 ±3.91 28.20𝑎𝑏±6.57 64.80𝑎𝑏 ±6.90
T4 7.80𝑎 ±5.40 6.60𝑎 ±13.14 14.40𝑎 ±9.81 97.20𝑏 ±13.51
T5 4.20𝑎 ±7.82 22.80𝑎 ±17,80 43.20𝑏 ±25.94 49.80𝑎 ±40.72
T6 3.00𝑎 ±3.00 6.60𝑎 ±4.44 12.00𝑎 ±6.70 98.40𝑏 ±4.44
Note: The different superscript in one column shows significant difference (p<0.05)
T 3: Data of period comparison on mice estrous cycle after given IGF-I PMS and IGF-I recombinant
mouse in each phase (hour).
IGF-I Estrous Cycle (x±SD)
Proestrus Estrus Metestrus Diestrus
PMS 8.00𝑎 ± 6.07 10.40𝑎 ± 12.87 23.20𝑎± 19.45 78.60𝑎 ± 30.51
Recombinant mouse 5.00𝑎 ± 5.74 12.00𝑎 ±14.43 23.20𝑎 ±21.16 81.80𝑎 ±32.87
Note: The same superscript in one column does not shows significant difference (p<0.05).
recombinant mouse causes metestrus phase period stay longer significantly (p<0.05)
in the P22 treatment, while diestrus phase period is significantly longer (p<0.05) in the
treatment of P4 and P6. The result of mice’s vaginal smear in estrous cycle after given
IGF-I PMS and IGF-I recombinant mouse is presented in Table 3.
Based on the result of vagina smear of mice in estrous cycle after given IGF-I PMS,
there is no significant difference (p>0.05) with themice which have given IGF-I recom-
binant mouse.
The result of estrous cycle after vagina smear is shown by the existence of nucleated
epithelial cells, gore epithelial cell, and leukocytes. Nucleated epithelial cells occured in
proestrus phase; cornified epithelial cell occured in estrus phase, especially in vagina
smear; in metestrus phase, many cornified epithelial cells and leukocytes are found;
and in dietrus phase, there are many leukocytes are evenly found. Proestrus phase is
a transition phase from diestrus to estrus in which the estrus symptom start to appear
yet female animals do not accept mating from the males. This phase is marked by the
growth of follicle into de Graaf follicle. The period is not significantly different (p>0.05)
toward all treatments: IGF-I PMS and IGF-I recombinant mouse.
Estrous is a transition phase from proestrus to metestrus. This phase is marked by
the receipt male animals by females to do copulation. The period of this phase will be
longer after given IGF-I PMS, while there is no significant difference (p>0.05) by giving
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Figure 1: Cytology of mice’s vaginal smear in proestrus phase, (A) nucleated epithelial cell, 2. Cytology of
mice’s vaginal smear estrous phase, (B) cornified cell, 3. Cytology of mice’s vaginal smear in metestrus
phase, (C) leukocyte cell, 4.Cytology of mice’s vaginal smear in diestrus phase (Giemsa staining, 400x
magnification).
IGF-I recombinant mouse. Adding IGF-I PMS shows a significant alteration on estrous
phase (p<0.05) in T3 handling with 40 ng/ml doses.
Metestrus is a transition phase from estrous to diestrus (luteal phase). This phase
has high rate of estrogen which cause positive feedback from anterior pituitary to
release LH. From this case, when LH is increasing, estrogen will be decreasing and
pre-ovulatory will occur. The high rates of LH is the beginning of metestrus phase and
followed by ovulation. Giving various doses of IGF-I PMS in this phase did not show
significant difference (p>0.05) comparing to C0. On the other hand, IGF-I recombinant
mouse made metestrus phase goes longer significantly (p<0.05) in T5 treatment and
dose of 20 ng/ml.
Diestrus is the phase after metestrus when the objects were given IGF-I PMS in the
treatments of T1, T2, and T3, the change of phase was longer yet there was no signif-
icant differences between the treatment (p>0.05). Meanwhile, giving IGF-I recombi-
nant mouse with the treatments of T4 and T6toward the objects showed that diestrus
phase period is significantly longer (p<0.05) comparing to C0 (Table 2). The change
of diestrus phase is longer because of the high rates of progesterone level in the
blood vessels. This progesterone level is produced by corpus luteum after ovulation.
In other words, IGF-I PMS addition with various doses do not relieve the function of
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T 4: The amount of mice litter sizes after given IGF-I PMS and IGF-I recombinant mouse
subcutaneously.
Treatment Doses IGF-I Pregnant Crossbreed Mare Serum IGF-I Recombinant Mouse
C0 3.80𝑏±2.28 3.80𝑏 ±2.28
10 ng/ml 5.40𝑎𝑏 ±1.67 4.60𝑎𝑏 ±0.89
20 ng/ml 7.40𝑎𝑏 ±1.95 5.40𝑎𝑏 ±1.34
40 ng/ml 8.40𝑎 ±2.97 7.80𝑎𝑏 ±3.03
Note: The different superscript in the same row shows significant difference (p<0.05)
progesterone in diestrus phase. Overall, domination of progesterone is the reason why
diestrus phase period gets longer although adding IGF-I PMS can increase estrogen
secretion.
The effect of giving IGF-I PMS and IGF-I recombinant mouse toward estrous cycle did
not show significant difference (p>0.05) based on the statistical result. This indicates
mechanismwork of either IGF-I PMS and IGF-I recombinantmouse have the same level
of efficiency.
3.2. The effect of IGF-I PMS and IGF-I recombinant mouse
toward the amount of mice
The result of giving IGF-I PMS and IGF-I recombinant mouse on female mice in this
research subcutaneously showed good response toward the amount of mice litter.
Monitoring result of mice litter will be presented in Table 4.
This research used ANOVA to analyze statistically toward the amount of mice litter
by giving them IGF-I pregnant crossbreed mare serum rather than IGF-I recombinant
mouse subcutaneously. The result is not significantly different (p<0.05) and from this
result it can be seen that giving IGF-I PMS subcutaneously has the same level of
efficiency with IGF-I recombinant mouse toward the amount of mice litter.
The doses that are given in this research are various. With C0 which contains 0.1 ml
of physiological NaCl, the number of mice litter is fewer than if they are given IGF-I
pregnant crossbreed mare serum and IGF-I recombinant mouse. By giving IGF-I PMS
with doses of T1 10 ng/ml, T2 20 ng/ml, and T3 40 ng/ml consecutively, the obtained
mice will increase with the numbers are follows: 5.40±1.67; 7.40±1.95; 8.40±2.97. This
shows that there are different results based on the doses given. An optimal result
can be reached by giving dose of T3 40 ng/ml of IGF-I PMS. In addition, giving IGF-I
recombinant mouse provides different results as well, based on the doses given. Here
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are the numbers of obtainedmicewhen IGF-I recombinantmouse is added: 4.60±0.89;
5.40±1.34; 7.80±3.03. It shows a good result in the dose of T6 40 ng/ml. In this research,
it can be seen that the number of mice in T3 is significantly different from group ofC0.
Meanwhile, in the groups of T1, T2, T4, T5, and T6 are not significantly different from
C0 although there is an enhancement of mice litter number here. This is due to some
factors, such as the condition of female mice hormones, how the substance given,
and the environmental factor. Moreover, the comparison result shows that there is
no significant difference between IGF-I pregnant crossbreed mare serum and IGF-I
recombinant mouse.
4. Discussion
4.1. The effect of IGF-I PMS and IGF-I recombinant mouse
on mice estrous cycle
Estrous cycle is the sexual cycle which is happened in female animal. It is divided
into two phases: follicular and luteal. Follicular is a phase where follicle develops until
the outbreak of de Graaf follicle (ovulation). This phase causes proestrus and estrous
symptoms. On the other hand, luteal is a phase after ovulation in which it is follow-
ing the period of progesterone secretion and the phase of corpus luteum formation.
This phase causes metestrus and diestrus symptoms [22]. This shows a connection
between IGF-I PMS and hormonal condition on female mice, and its effect on estrous
cycle.
Estrus phase, estrogen and LH reach the highest rate, while it reaches the lowest rate
in diestrus phase [23]. Besides, the follicle size will be getting bigger. The bigger follicle
size, the estrogen synthesis will increase as well [24]. Because the estrogen hormone
increases, the period of estrous phase will be longer. According to [25], the long period
of estrous phase will be important implication for mice reproduction because they
have long mating. Moreover, long extension phase of estrous if they are given IGF-I
PMS with T3 comparing to C0, it would be more benefit and has significant potential
in terms of fertilization.
Metestrus phase according to [26], the high rates of estrogen causes vasculariza-
tion from endometrium. Maximum vascularization occured in the end of the phase.
It dropped down causing blood vessels are back to former position and it could be
seen there are many ruptured capillaries thus leukocytes are found in vaginal smear.
Diestrus is the phase after metestrus. This phase lasted 60-70 hours [27].
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4.2. The effect of IGF-I PMS and IGF-I recombinant mouse
toward the amount of mice
There are some factors that affect a variation number of mice litter in every treatment,
such as the object, the given doses, the given IGF-I pregnant crossbreed mare serum
and IGF-I recombinant mouse, and injection time. The animals that are used to be an
object is really influential for research, especially for the hegemonity. It is because of
different response of super ovulation female animals give, based on the species, life
weight, lust cycle phase, age, parturition post interval, season, and feed [28]. There
are might some differences in life weight and age of the objects of this research and
this can affect their reproduction.
The use of both IGF-I pregnant crossbreed mare serum and IGF-I patent determines
the number of maturated cow’s oocyte. The raise of maturated oocyte percentage
indirectly hands in hand with the percentage of embryo cleavage. Giving IGF-I also
raises the number of pigs oocyte cleavage, fertilization, pro-nucleus formation, and
embryo growth percentage at the stage of 8-cell. IGF-I supplementation can increase
the amount of cows embryo in vitro by stimulating expansion or cumulus expansion,
oxidative metabolism, maturation core, cleavage, and fertilization. In rabbits, giving
IGF-I to their oocyte can increase maturation core [16, 29].
Insulin-like growth factor-I has important role in follicle growth, follicle growth
dominant, and steroidogenesis. IGF-I will increase LH or human Chorionic Gonadotropin
(hCG) stimulation will release androgen. FSH induces steroidogenesis and causes
growth, also differentiates follicle cells as well. IGF-I maternal mediates the effect
from FSH toward ovary and generates follicle growth in the beginning of pregnancy of
mare type Thoroughbred. Estrogen can raise IGF-I plasma through IGF-I escalation from
the liver or follicle. IGF-I level on follicle is positively connected with the diameter of
cows’ antral follicle during pregnancy [30]. Insulin-like growth factor-I and IGFBP-I are
able to intensify embryo culture in vitro with something related to cell death reduction.
Mediation arrangements in vivo by IGF-I, IGF-IR, and IGFBP-I called Intraovarian IGF-
IGFBP system have important role in process of follicle growth, oocyte maturation and
ovulation, and embryo growth [31].
The level of IGF-I concentration on blood vessels of cattles which have not entered
puberty will decrease and cause a delay of puberty. This is related to the lower-
ing number of follicle growth and it can undermine the ability of ovary in producing
estradiol, so that it will postpone LH stimulation [32]. Stated of [33] that adding IGF-I
toward heifer is signed as the possibility of puberty occurence when somatic grows as
DOI 10.18502/kls.v3i6.1126 Page 184
VMIC 2017
planned. IGF-I in granulosa cells and theca cells from ovary follicle stimulates recep-
tor cells type I. Afterwards, in autocrine manner, IGF-I will stimulate the proliferation
and diferentiation of granulosa cells. While in paracrine infusion, IGF-I will stimulate
steroid secretion (stereidogenesis) from ovary by raising androstendion and estradiol
production. This indicates that IGF-I works by affecting steroid production in granulosa
cells and theca cells in ovary follicles. The escalation of androstendione and estradiol
production affects anterior pituitary to increase LH secretion (feedback positive). The
raising of LH production (LH abundant) causes the increasing of bloodstream into ovary.
With the help of enzyme (ovulatory lytic enzym), follicle will rupture and ovulation
happens.
5. Conclusion
The addition of insulin-like growth factor-I(IGF-I) derived from pregnant crossbred
mare serum (PMS) can extend estrous phase in estrous cycle and increase the amount
of mice litter sizes (Mus musculus). Giving IGF-I PMS will affect as well as giving IGF-I
recombinant mouse toward estrous cycle (proestrus, estrus, metestrus, and diestrus
phase) and the amount of mice litter (Mus musculus). IGF-I pregnant crossbred mare
serum and IGF-I recombinant mouse are interchangeable or just as good.
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